Company: WELNF
Filing Date: 2025-11-12
Form Type: DEFM14A
Source: 0001104659-25-109577
Chunk: 163

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-11-12
Form: DEFM14A
Chunk 163
---
 ten business days thereafter, redeem the Public Shares on a pro rata basis, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to IWAC net of taxes payable, if any, divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly

<div align='center'>62</div>

TABLE OF CONTENTS

as reasonably possible following such redemption, subject to the approval of IWAC’s remaining shareholders and its board of directors, liquidate and dissolve, subject in each case to its obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to IWAC’s warrants, which will expire and be worthless if IWAC fails to consummate an initial business combination by December 15, 2025, or such later date as may be approved by IWAC’s shareholders. The Existing Organizational Documents provide that, if it winds up for any other reason prior to the consummation of the initial business combination, IWAC will follow the foregoing procedures with respect to the liquidation of the Trust Account as promptly as reasonably possible but not more than ten business days thereafter, subject to applicable Cayman Islands law. In such case, based on the amount of funds on deposit in the Trust Account as of November 3, 2025, IWAC’s Public Shareholders would receive only approximately $12.78 per Public Share upon the redemption of their shares and their warrants would expire worthless.

Because the market price of shares of Pubco common stock will fluctuate, Btab’s stockholders cannot be certain of the value of the merger consideration they will receive until the Closing of the Business Combination.

Upon completion of the Business Combination, each share of Btab common stock will be converted into the right to receive shares of Pubco common stock. The stock component of the merger consideration that Btab stockholders will receive is a fixed number of shares of Pubco common stock; it is not a number of shares with a particular fixed market value. The market price of Pubco common stock at the Closing of the Business Combination may vary significantly from its price on the date the Business Combination Agreement was executed or on other dates. Stock price changes may result from a